Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-Current DebtOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Capital Expenditures: 2019-2025

Historic Capital Expenditures for Legend Biotech (LEGN) over the last 4 years, with Mar 2025 value amounting to $545,000.

  • Legend Biotech's Capital Expenditures fell 3.20% to $545,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.6 million, marking a year-over-year decrease of 36.25%. This contributed to the annual value of $14.1 million for FY2024, which is 29.77% down from last year.
  • Latest data reveals that Legend Biotech reported Capital Expenditures of $545,000 as of Q1 2025, which was up 45.72% from $374,000 recorded in Q4 2024.
  • In the past 5 years, Legend Biotech's Capital Expenditures ranged from a high of $2.2 million in Q2 2021 and a low of $1,663 during Q1 2021.
  • In the last 3 years, Legend Biotech's Capital Expenditures had a median value of $451,000 in 2023 and averaged $697,444.
  • In the last 5 years, Legend Biotech's Capital Expenditures skyrocketed by 261,529.63% in 2021 and then plummeted by 74.33% in 2024.
  • Over the past 5 years, Legend Biotech's Capital Expenditures (Quarterly) stood at $2.2 million in 2021, then tumbled by 57.84% to $914,000 in 2022, then crashed by 50.66% to $451,000 in 2023, then declined by 17.07% to $374,000 in 2024, then fell by 3.20% to $545,000 in 2025.
  • Its Capital Expenditures was $545,000 in Q1 2025, compared to $374,000 in Q4 2024 and $376,000 in Q3 2024.